Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
Scheme Name
 
NAV Rs. As
On 26-04-24
Inception
Date
1 Year
%
3 Years
%
5 Years
%
Since Inception
%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G) 30.78 13-Jul-18 59.81 18.24 24.45 21.42
Tata India Pharma & Healthcare Fund-Reg(G) 25.18 28-Dec-15 54.41 16.86 22.13 11.71
Nippon India Pharma Fund(G) 429.06 05-Jun-04 53.12 16.58 22.65 20.79
DSP Healthcare Fund-Reg(G) 32.45 30-Nov-18 51.82 16.49 25.51 24.33
Mirae Asset Healthcare Fund-Reg(G) 31.28 02-Jul-18 50.31 15.84 23.75 21.64
Aditya Birla SL Pharma & Healthcare Fund-Reg(G) 26.26 10-Jul-19 55.94 15.02 NA 22.28
LIC MF Healthcare Fund-Reg(G) 24.16 28-Feb-19 48.05 11.47 18.94 18.64
ITI Pharma & Healthcare Fund-Reg(G) 13.60 08-Nov-21 48.14 NA NA 13.27
Kotak Healthcare Fund-Reg(G) 11.33 11-Dec-23 NA NA NA 13.26
Quant Healthcare Fund-Reg(G) 13.91 17-Jul-23 NA NA NA 39.05
HDFC Pharma and Healthcare Fund-Reg(G) 12.52 04-Oct-23 NA NA NA 25.66
WOC Pharma and Healthcare Fund-Reg(G) 10.10 06-Feb-24 NA NA NA 1.02
Page 1 of 1
Prev || Next
 Back
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.